Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report

INTRODUCTION: The efficacy of erlotinib in advanced non-small-cell lung cancer has been demonstrated in several trials, but only two cases of complete and prolonged response in wild-type epidermal growth factor receptor locally advanced lung cancer have been published. CASE PRESENTATION: We discuss...

Full description

Saved in:
Bibliographic Details
Main Authors: Vitale, Maria Giuseppa, Riccardi, Ferdinando, Mocerino, Carmela, Barbato, Carmela, Monaco, Roberto, Galloro, Paola, Gagliardi, Nicola, Cartenì, Giacomo
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978081/
https://ncbi.nlm.nih.gov/pubmed/24661457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-102
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items